Trial intelligence / Profile preview

Sevoflurane versus propofol anesthesia for cardioprotection in OPCABG

ChiCTR-TRC-13004035Phase 4Completed

Sponsor
Xiangya Hospital, Central South University
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of sevoflurane and propofol in coronary arteriosclerosis (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: microRNA-499 and microRNA-208b. Started Jan 2011; status: completed.

02

Drugs

sevofluranepropofol
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ChiCTR-TRC-13004035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13004035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call